Varian "inspires," rewrites software

Article

Engineers at Varian Medical have crafted a radiation oncology management system designed to simplify and facilitate delivery of advanced radiation therapy for treating cancer. The product, called Inspiration, was the focus of the company's exhibit Oct.

Engineers at Varian Medical have crafted a radiation oncology management system designed to simplify and facilitate delivery of advanced radiation therapy for treating cancer. The product, called Inspiration, was the focus of the company's exhibit Oct. 19 at the ASTRO annual meeting. Inspiration links all clinical activities, from imaging to planning, simulating, verifying, and delivering treatments. It is based on a unified database and information management system to which all devices and processes are tied.

Varian also displayed a redesigned version of its VARiS Vision radiation oncology management software. Enhancements streamline and accelerate processes involved in treating cancer with radiation therapy. The software simplifies the many steps involved in delivering a multiweek course of radiation therapy, including treatment planning, simulation, and scheduling.

Amid the technology and glitz of ASTRO, Varian executives heaped good financial news on shareholders, announcing their expectation that earnings in the fourth quarter of fiscal 2003 would rise by 26% to 27% over the year-earlier period. Net orders were expected to be 10% higher.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.